N3-Heteroaryl substituted triazoles and N5-heteroaryl substituted triazolesand pharmaceutical compositions containingthe compounds are disclosed as being useful in inhibiting the activity of thereceptor protein tyrosine kinase Axl. Methodsof using the compounds in treating diseases or conditions associated with Axlactivity are also disclosed.